Stereotaxis, Inc. (STXS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1161071,
    "name": "Stereotaxis, Inc.",
    "stock_name": "Stereotaxis, Inc.",
    "full_name": "Stereotaxis, Inc.",
    "name_url": "stocks-analysis/stereotaxis-inc",
    "exchange": 215,
    "exchangecode": "ASE",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.43",
    "chg": 0.1,
    "chgp": "4.29%",
    "dir": 1,
    "prev_price": "2.33",
    "mcapval": "262.30",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US85916J4094",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "729.54 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/stereotaxis-inc-1161071-215&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Stereotaxis, Inc. Hits New 52-Week High of $3.58, Marking Key Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/stereotaxis-inc-hits-new-52-week-high-of-358-marking-key-milestone-3608002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/StereotaxisInc_priceRelatedfactors_3608002.png",
        "date": "2025-10-09 20:07:38",
        "description": "Stereotaxis, Inc. has achieved a new 52-week high of USD 3.58, significantly up from its low of USD 1.54. Despite this milestone, the company has seen a slight decline in performance over the past year, with a market capitalization of USD 262 million and notable financial challenges."
      },
      {
        "title": "Stereotaxis, Inc. Hits New 52-Week High at USD 3.37",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/stereotaxis-inc-hits-new-52-week-high-at-usd-337-3604306",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/StereotaxisInc_priceRelatedfactors_3604306.png",
        "date": "2025-10-08 16:43:18",
        "description": "Stereotaxis, Inc. has achieved a new 52-week high of USD 3.37, contrasting with its 52-week low of USD 1.54. Despite this milestone, the company has seen a 1-year performance decline of 11.17%. Currently, Stereotaxis is loss-making, with a market capitalization of USD 262 million."
      },
      {
        "title": "Stereotaxis, Inc. Hits New 52-Week High at $3.33",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/stereotaxis-inc-hits-new-52-week-high-at-333-3601604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/StereotaxisInc_priceRelatedfactors_3601604.png",
        "date": "2025-10-07 21:47:17",
        "description": "Stereotaxis, Inc. has achieved a new 52-week high of USD 3.33 as of October 6, 2025, despite a 1-year performance decline of 7.82%. The company, with a market capitalization of USD 262 million, is currently loss-making and does not offer dividends, reflecting challenges in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Stereotaxis, Inc. Hits New 52-Week High at USD 3.20",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/stereotaxis-inc-hits-new-52-week-high-at-usd-320-3588358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/StereotaxisInc_priceRelatedfactors_3588358.png",
        "date": "2025-10-02 22:32:21",
        "description": "Stereotaxis, Inc. has achieved a new 52-week high of USD 3.20 as of October 1, 2025, significantly up from its low of USD 1.54. The company, with a market cap of USD 262 million, is currently loss-making and has a high price-to-book ratio, reflecting its challenging financial position."
      },
      {
        "title": "Stereotaxis, Inc. Hits New 52-Week High of $3.07",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/stereotaxis-inc-hits-new-52-week-high-of-307-3565262",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/StereotaxisInc_priceRelatedfactors_3565262.png",
        "date": "2025-09-24 13:24:18",
        "description": "Stereotaxis, Inc. has achieved a new 52-week high of USD 3.07, contrasting with a low of USD 1.54. Despite this milestone, the company has seen a 1-year performance decline of 18.16%. With a market cap of USD 262 million, Stereotaxis remains loss-making and faces challenges in the competitive pharmaceuticals sector."
      },
      {
        "title": "Is Stereotaxis, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-stereotaxis-inc-technically-bullish-or-bearish-3546312",
        "imagepath": "",
        "date": "2025-09-20 19:29:24",
        "description": "As of 8 August 2025, the technical trend for Stereotaxis, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. However, the weekly RSI is bearish, indicating some short-term weakness. The daily moving averages are bullish, and the KST is bullish on both weekly and monthly time frames. The Bollinger Bands show a mildly bullish stance on both weekly and monthly periods. The Dow Theory indicates a mildly bullish trend on the weekly chart but no trend on the monthly.\n\nIn terms of performance, Stereotaxis has outperformed the S&P 500 year-to-date with a return of 22.81% compared to the S&P's 12.22%, and over the past year, it has returned 43.59% versus the S&P's 17.14%. However, over longer periods, such as 3 years and 5 years, it has significantly underperformed the benchmark.\n\nOverall, the current technical stance is bullish, d..."
      },
      {
        "title": "Is Stereotaxis, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-stereotaxis-inc-overvalued-or-undervalued-3542905",
        "imagepath": "",
        "date": "2025-09-20 18:05:22",
        "description": "As of 9 May 2019, the valuation grade for Stereotaxis, Inc. moved from fair to risky, indicating a deterioration in its investment appeal. The company is overvalued, as evidenced by its high Price to Book Value of 23.67 and negative EV to EBIT and EV to EBITDA ratios of -7.08 and -7.42, respectively. Additionally, the Return on Equity (ROE) is alarmingly low at -310.19%, reflecting significant financial distress.\n\nIn comparison to its peers, Stereotaxis, Inc. exhibits a notably worse valuation profile; for instance, Bioventus, Inc. has a P/E ratio of 72.81, while Semler Scientific, Inc. is considered attractive with a P/E ratio of 32.26. The stock has shown mixed performance against the S&P 500, with a year-to-date return of 22.81% compared to the index's 12.22%, but a disappointing 5-year return of -25.73% versus the S&P 500's impressive 96.61%...."
      }
    ],
    "total": 12,
    "sid": "1161071",
    "stock_news_url": "https://www.marketsmojo.com/news/stereotaxis-inc-1161071"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Stereotaxis, Inc. Hits New 52-Week High of $3.58, Marking Key Milestone

2025-10-09 20:07:38

Stereotaxis, Inc. has achieved a new 52-week high of USD 3.58, significantly up from its low of USD 1.54. Despite this milestone, the company has seen a slight decline in performance over the past year, with a market capitalization of USD 262 million and notable financial challenges.

Stereotaxis, Inc. Hits New 52-Week High at USD 3.37

2025-10-08 16:43:18

Stereotaxis, Inc. has achieved a new 52-week high of USD 3.37, contrasting with its 52-week low of USD 1.54. Despite this milestone, the company has seen a 1-year performance decline of 11.17%. Currently, Stereotaxis is loss-making, with a market capitalization of USD 262 million.

Stereotaxis, Inc. Hits New 52-Week High at $3.33

2025-10-07 21:47:17

Stereotaxis, Inc. has achieved a new 52-week high of USD 3.33 as of October 6, 2025, despite a 1-year performance decline of 7.82%. The company, with a market capitalization of USD 262 million, is currently loss-making and does not offer dividends, reflecting challenges in the Pharmaceuticals & Biotechnology sector.

Stereotaxis, Inc. Hits New 52-Week High at USD 3.20

2025-10-02 22:32:21

Stereotaxis, Inc. has achieved a new 52-week high of USD 3.20 as of October 1, 2025, significantly up from its low of USD 1.54. The company, with a market cap of USD 262 million, is currently loss-making and has a high price-to-book ratio, reflecting its challenging financial position.

Stereotaxis, Inc. Hits New 52-Week High of $3.07

2025-09-24 13:24:18

Stereotaxis, Inc. has achieved a new 52-week high of USD 3.07, contrasting with a low of USD 1.54. Despite this milestone, the company has seen a 1-year performance decline of 18.16%. With a market cap of USD 262 million, Stereotaxis remains loss-making and faces challenges in the competitive pharmaceuticals sector.

Is Stereotaxis, Inc. technically bullish or bearish?

2025-09-20 19:29:24

As of 8 August 2025, the technical trend for Stereotaxis, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. However, the weekly RSI is bearish, indicating some short-term weakness. The daily moving averages are bullish, and the KST is bullish on both weekly and monthly time frames. The Bollinger Bands show a mildly bullish stance on both weekly and monthly periods. The Dow Theory indicates a mildly bullish trend on the weekly chart but no trend on the monthly. In terms of performance, Stereotaxis has outperformed the S&P 500 year-to-date with a return of 22.81% compared to the S&P's 12.22%, and over the past year, it has returned 43.59% versus the S&P's 17.14%. However, over longer periods, such as 3 years and 5 years, it has significantly underperformed the benchmark. Overall, the current technical stance is bullish, d...

Is Stereotaxis, Inc. overvalued or undervalued?

2025-09-20 18:05:22

As of 9 May 2019, the valuation grade for Stereotaxis, Inc. moved from fair to risky, indicating a deterioration in its investment appeal. The company is overvalued, as evidenced by its high Price to Book Value of 23.67 and negative EV to EBIT and EV to EBITDA ratios of -7.08 and -7.42, respectively. Additionally, the Return on Equity (ROE) is alarmingly low at -310.19%, reflecting significant financial distress. In comparison to its peers, Stereotaxis, Inc. exhibits a notably worse valuation profile; for instance, Bioventus, Inc. has a P/E ratio of 72.81, while Semler Scientific, Inc. is considered attractive with a P/E ratio of 32.26. The stock has shown mixed performance against the S&P 500, with a year-to-date return of 22.81% compared to the index's 12.22%, but a disappointing 5-year return of -25.73% versus the S&P 500's impressive 96.61%....

View All News